Skip to main content
. 2019 Sep 13;11(9):1365. doi: 10.3390/cancers11091365

Figure 1.

Figure 1

Best prostate-specific antigen (PSA) response according to circulating tumor cells/androgen receptor splice variant 7 (CTC/AR-V7) status (A) and number of androgen receptor full-length (AR-FL) copies (B).